LRRK2通过促进MFN2降解和异常的线粒体完整性来加剧损伤
Shun Zhang1, Subo Qian1, Hailong Liu1
1Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.
Redox biology
|August 26, 2023
概括
富含白的重复激酶2 (LRRK2) 下调保护通过稳定线粒体蛋白质,防止急性损伤 (AKI) 和纤维化. 抑制LRRK2可能为脏疾病提供治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 线粒体生物学 线粒体生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 线粒体功能障碍是急性损伤 (AKI) 和随后的纤维化的主要原因.
- 氨酸丰富的重复激酶2 (LRRK2) 在脏线粒体平衡中起作用,但其在AKI中的功能仍然不清楚.
研究的目的:
- 研究LRRK2在AKI的发病过程中的作用及其向慢性病 (CKD) 的进展.
- 探索LRRK2作为AKI和纤维化的潜在治疗标.
主要方法:
- 使用Lrrk2淘汰赛 (Lrrk2-/-) 小鼠和人类近壁管细胞 (PTC) 线.
- 使用缺血/再输血 (I/R) 模型诱导的AKI.
- 评估了线粒体形态,反应性氧物种 (ROS) 生产和蛋白质水平 (MFN2).
- 研究了LRRK2-介导的酸化和降解途径.
主要成果:
- 在AKI脏中,LRRK2表达显著降低.
- Lrrk2-/-小鼠的AKI严重程度降低,其特征是线粒体碎片化和ROS产生较少,与MFN2积累有关.
- 在PTC中LRRK2过度表达增强了MFN2的酸化和降解,恶化了线粒体损伤.
- LRRK2 缺乏减轻了 AKI 到 CKD 的过渡,并减少了纤维化.
- 在体内LRRK2抑制改善了AKI和CKD的严重程度.
结论:
- LRRK2下调是AKI的一个特征,并有助于其严重性.
- 通过增强MFN2降解和随后的线粒体功能障碍,LRRK2促进AKI和纤维化.
- 用抑制剂向LRRK2是一种有希望的治疗方法,可以缓解AKI和纤维化.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Acute Kidney Injury II: Pathophysiology
26
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
Nephrons
2.7K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.7K
Acute Kidney Injury I: Introduction
28
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K


